Home > Insider Trading > Filing (0001624794-24-000100)

Filing Details

Accession Number:: 0001624794-24-000100
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-12-16 17:31:26
Reporting Period:: 2024-12-16

Accepted Time:: 2024-12-16 17:31:26
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1624794	Csw Industrials Inc.	CSWI	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1413614	B Joseph Armes	5420 Lyndon B Johnson Fwy Ste. 500 Dallas TX 75240-1007	Chairman, President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2024-12-16	51	$387.58	50,647	No	4	S	Direct
Common Stock	Disposition	2024-12-16	319	$388.80	50,328	No	4	S	Direct
Common Stock	Disposition	2024-12-16	359	$389.80	49,969	No	4	S	Direct
Common Stock	Disposition	2024-12-16	208	$391.02	49,761	No	4	S	Direct
Common Stock	Disposition	2024-12-16	52	$392.07	49,709	No	4	S	Direct
Common Stock	Disposition	2024-12-16	11	$393.38	49,698	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,500	Indirect	JBA Family Partners, L.P.
Common Stock	3,142	Indirect	by ESOP

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Performance Rights	$0.00	8,236	8,236	Direct
Common Stock	Performance Rights	$0.00	12,422	12,422	Direct
Common Stock	Performance Rights	$0.00	7,851	7,851	Direct
Common Stock	Performance Rights	$0.00	27,559	27,559	Direct
Common Stock	Restricted Stock Units	$0.00	19,685	19,685	Direct

Amount	Remaning Holdings	Nature of Ownership
8,236	8,236	Direct
12,422	12,422	Direct
7,851	7,851	Direct
27,559	27,559	Direct
19,685	19,685	Direct

Footnotes

The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $387.15 to $387.89, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $388.46 to $389.305, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $389.465 to $390.23, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $390.545 to $391.47, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $391.58 to $392.55, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $393.075 to $393.675, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2024 and ending on March 31, 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2023 and ending on March 31, 2026 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2022 and ending on March 31, 2025 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest in three equal amounts, at a rate between 0% and 200%, during three performance cycles ending on each of March 31, 2025, 2026, and 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock at vesting. 40% of the restricted stock units vest no earlier than April 26, 2025 upon the successful recruitment and hiring of a successor Chief Executive Officer; the remaining 60% vest upon the successful first employment anniversary of a successor Chief Executive Officer.